Regene LLC
Belchertown, MA
- UEI
- U1CES2AME9A8
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 274 Hamilton St, Belchertown, MA 01007, USA
- Website
- regenbio.net
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Targeting type 3 diabetes (T3D) mechanism of alzheimer's disease (ad) and ad-related dementias | National Institute on Aging (NIH) | $999,980 |
Quick answers
Is Regene LLC registered in SAM.gov?
Yes. Regene LLC's SAM.gov registration is active through July 19, 2027.
What is Regene LLC's most recent federal award?
Regene LLC's most recent federal grant award is Targeting type 3 diabetes (T3D) mechanism of alzheimer's disease (ad) and ad-related dementias (R43AG085738), from National Institute on Aging (NIH), on February 1, 2024.
On GovTribe
See Regene LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors